Skip to main content

Main menu

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Other Publications
    • cbm

User menu

  • My alerts

Search

  • Advanced search
Cancer Biology & Medicine
  • Other Publications
    • cbm
  • My alerts
Cancer Biology & Medicine

Advanced Search

 

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Follow cbm on Twitter
  • Visit cbm on Facebook
OtherPerspective
Open Access

Current and future trends in whole genome sequencing in cancer

Yuki Katsuya
Cancer Biology & Medicine January 2024, 21 (1) 16-20; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0420
Yuki Katsuya
Department of Experimental Therapeutics, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Yuki Katsuya
  • For correspondence: [email protected]
  • Article
  • Figures & Data
  • Info & Metrics
  • References
  • PDF
Loading

Article Figures & Data

Figures

  • Figure 1
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1

    Overview of the “The Action Plan for Whole Genome Analysis for Cancer and Rare/intractable Diseases” WGS project in Japan. WGS, whole genome sequencing; PPI, patient and public involvement; ELSI, ethical, legal, and social issues. Modified from “Action Plan for Whole Genome Analysis 2022”16.

  • Figure 2
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 2

    The WGS project’s implementation and collaboration system. Modified from “Action Plan for Whole Genome Analysis 2022”16.

PreviousNext
Back to top

In this issue

Cancer Biology & Medicine: 21 (1)
Cancer Biology & Medicine
Vol. 21, Issue 1
15 Jan 2024
  • Table of Contents
  • Index by author
Print
Download PDF
Email Article

Thank you for your interest in spreading the word on Cancer Biology & Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Current and future trends in whole genome sequencing in cancer
(Your Name) has sent you a message from Cancer Biology & Medicine
(Your Name) thought you would like to see the Cancer Biology & Medicine web site.
Citation Tools
Current and future trends in whole genome sequencing in cancer
Yuki Katsuya
Cancer Biology & Medicine Jan 2024, 21 (1) 16-20; DOI: 10.20892/j.issn.2095-3941.2023.0420

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Current and future trends in whole genome sequencing in cancer
Yuki Katsuya
Cancer Biology & Medicine Jan 2024, 21 (1) 16-20; DOI: 10.20892/j.issn.2095-3941.2023.0420
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • WGS: current state
    • Clinical implementation of WGS in the UK and the Netherlands
    • Clinical implementation of WGS in Japan
    • Future directions
    • Conflicts of interest statement
    • References
  • Figures & Data
  • Info & Metrics
  • References
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • XPO1 as a key regulator in small cell lung cancer: mechanisms, biomarkers, and therapeutic implications
  • The evidence and concerns about screening ultrasound for breast cancer
  • Insights into the DNA damage response and tumor drug resistance
Show more Perspective

Similar Articles

Navigate

  • Home
  • Current Issue

More Information

  • About CBM
  • About CACA
  • About TMUCIH
  • Editorial Board
  • Subscription

For Authors

  • Instructions for authors
  • Journal Policies
  • Submit a Manuscript

Journal Services

  • Email Alerts
  • Facebook
  • RSS Feeds
  • Twitter

 

© 2025 Cancer Biology & Medicine

Powered by HighWire